Correction: Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma
Suzette Girgis1, Shun Xin Wang Lin2, Kodandaram Pillarisetti2
1Janssen Research & Development, 920 Route 202, Raritan, NJ, 08869, USA. SGirgis@its.jnj.com.
Targeted Oncology
|August 1, 2022
Abstract
No abstract available in PubMed .
More Related Videos
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.3K
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
8.7K
